Veeva expands clinical solution offerings, hires former PPD VP

By Melissa Fassbender

- Last updated on GMT

(Image: iStock/lekstuntkite)
(Image: iStock/lekstuntkite)

Related tags Clinical trial Vice president

Veeva has announced two new products and a series of new hires across its product management team after nearly doubling its customers over the past year.

The new products, Veeva Vault EDC and Veeva Vault eSource, extends the company’s clinical solution to includeclinical data management and clinical document management.

According to the company, the Veeva Vault Clinical Suite now includes Vault EDC and Vault eSource, as well as Vault CTMS, Vault eTMF, and Vault Study Startup.

Vault EDC and Vault eSource will be a natural extension of Veeva’s modern, industry-specific cloud clinical suite, and build on the overall success of Vault Clinical – Veeva has nearly doubled the number of clinical customers this year​,” Henry Levy, Veeva’s new chief strategy officer, formally PPD’s executive vice president, told

Specifically, Vault EDC and Vault eSource will make it easy and efficient for life sciences companies to capture, manage, and share clinical trial data, including investigator data about patients​,” he explained.

Levy said the addition allows life sciences companies to – “for the first time​” – unify clinical operations and data management.

The applications will form the only integrated solution that ensures high-quality data at the point of entry in Vault eSource through to the EDC system​,” he said.

Streamlining the clinical landscape

According to Levy, traditional EDC solutions add to the cost and complexity of clinical trials by requiring site staff to spend large amounts of time handling data.

System set-up, maintenance, inflexibility, and a lack of integration between other vital clinical systems slow trials dramatically while hindering sponsors’ ability to get clean data quickly and make informed decisions during trials​,” he said.

The goal of the unified Veeva Vault Clinical suite is to streamline what Levy described as “an increasingly complex clinical landscapethat involves more external partners and other stakeholders than ever before​.”

Related topics Markets & Regulations

Related news

Show more